| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 02/07/2002 | WO2001074823A3 Fused heterocyclic derivatives, their production and use |
| 02/07/2002 | WO2000072802A3 Water soluble multi-biotin-containing compounds |
| 02/07/2002 | US20020016475 Does not require high pressure or temperature, not susceptible to air or sulfur poison; easy to handle |
| 02/07/2002 | DE10035997A1 Verwendung von anellierten Dihydropyridinen zur Herstellung von Mitteln für die Behandlung von chronischen Schmerzen Use of fused dihydropyridines for producing agents for the treatment of chronic pain |
| 02/06/2002 | CN1334812A Piperazine derivatives |
| 02/06/2002 | CN1334732A Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia |
| 02/05/2002 | US6344459 Treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis |
| 02/05/2002 | US6344449 Headache and morphine dependence |
| 02/05/2002 | US6344320 Electrophoresis of nascent proteins |
| 01/31/2002 | WO2002008215A1 Hyperpolarizable organic chromophores |
| 01/31/2002 | WO2002007714A2 Use of anellated dihydropyridines for the preparation of pharmaceutical compositions for the treatment of chronic pain |
| 01/31/2002 | WO2001021160A3 Carboxymide and aniline derivatives as selective inhibitors of pathogens |
| 01/31/2002 | US20020013476 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 01/31/2002 | US20020013460 Condensed pyridine compound |
| 01/31/2002 | US20020013354 p38 map kinase inhibitors |
| 01/31/2002 | US20020013334 HMG-CoA reductase inhibitors and method |
| 01/31/2002 | US20020013333 As inhibitors of matrix metalloproteinase, for therapy of diseases such as degenerative diseases and certain cancers |
| 01/31/2002 | US20020013310 Inhibitors of the activity of Factor Xa such as 3-((1-(4-Aminoquinolin-7-ylmethyl)-2-oxopyrrolidin-3-(R)-yl)-( 5- chloro-1H-indol-2-ylmethyl)amino)propionic acid methyl ester |
| 01/31/2002 | DE10034801A1 Substituierte Amidoalkyl-uracile und ihre Verwendung Substituted amidoalkyl uracils and their use |
| 01/31/2002 | CA2417000A1 Hyperpolarizable organic chromophores |
| 01/30/2002 | EP1176139A1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors |
| 01/30/2002 | EP0836602B1 Fungicidal pyrimidinones |
| 01/30/2002 | CN1333758A Substituted bicyclic derivatives useful as anticancer agents |
| 01/30/2002 | CN1333087A Ferrocence ruthenium phosphide complex and method for preparing d-thilane by exocyclic double-bond hydrogenation of d-thiophene using said complex as catalyst |
| 01/29/2002 | US6342601 Treating allograft rejection, rheumatoid arthritis |
| 01/29/2002 | US6342517 Potassium channel activators and their use |
| 01/29/2002 | US6342502 Thieno[2,3-d]pyrimidine diones and their use in the treatment of reversible obstructive airways diseases |
| 01/24/2002 | WO2002006361A2 Novel photochromic polymers and methods of synthesizing same |
| 01/24/2002 | WO2002006288A1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
| 01/24/2002 | WO2002006247A1 Substituted amidoalkyl-uracils as parp inhibitors |
| 01/24/2002 | WO2001058875A3 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives |
| 01/24/2002 | WO2001032655A3 Quinoline and naphthyridine carboxylic acid antibacterials |
| 01/24/2002 | WO2001027107A3 Heterocyclic sodium/proton exchange inhibitors and method |
| 01/24/2002 | US20020010297 High-molecular-weight polypropylene having a broad molecular-weight distribution |
| 01/24/2002 | US20020010204 Use as pesticides. |
| 01/24/2002 | US20020010189 For treatment of sexual disorders, male erectile dysfunction |
| 01/24/2002 | US20020010176 Integrin receptor antagonists |
| 01/24/2002 | CA2416036A1 Substituted amidoalkyl-uracils as parp inhibitors |
| 01/23/2002 | EP1173427A1 Hydroxamic acid derivative |
| 01/23/2002 | EP1173170A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/23/2002 | CN1332744A Tricyclic delta 3-piperidines as alpha 2-antagonists |
| 01/23/2002 | CN1332743A Cell adhesion-inhibiting antinflammatory compounds |
| 01/23/2002 | CN1332168A 3-substituted pyrido-[4',3':4,5] thieno-[2,3-d] pyrimidine derivatives, their prep. and use |
| 01/22/2002 | US6340759 Fused pyridine derivatives |
| 01/22/2002 | US6340686 Gonadotropin-releasing hormone antagonists |
| 01/22/2002 | US6340676 4-aryl-1-oxa-9-thia-cyclopenta (b) fluorenes |
| 01/17/2002 | WO2002004461A1 Hydropyridine derivative acid addition salts |
| 01/17/2002 | WO2002004460A1 Method for preparing (+)-biotine |
| 01/17/2002 | WO2002004459A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 01/17/2002 | WO2002004458A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 01/17/2002 | WO2002004455A2 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 01/17/2002 | WO2002004444A2 Heterocycle carboxamides as antiviral agents |
| 01/17/2002 | WO2002004426A1 Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists |
| 01/17/2002 | WO2001062726A3 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 01/17/2002 | WO2001039759A3 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 01/17/2002 | US20020007059 Potassium channel modulators relax smooth muscle cells and inhibit bladder contractions; treating nervous, eating, cardiovascular, gastrointestinal, and sexual disorders |
| 01/17/2002 | US20020006937 4-OXO-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents |
| 01/17/2002 | DE10033284A1 Verfahren zur Herstellung von (+)-Biotin A process for the preparation of (+) - Biotin |
| 01/17/2002 | DE10031390A1 Pyrimidinderivate und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie Pyrimidine derivatives and their use for the prophylaxis and therapy of cerebral ischemia |
| 01/17/2002 | DE10031389A1 Pyrimidinderivate und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie Pyrimidine derivatives and their use for the prophylaxis and therapy of cerebral ischemia |
| 01/17/2002 | DE10005302A1 Substituierte 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 01/16/2002 | EP1172418A2 Dye compounds having a terminal hydroxy, carboxylic acid/ester or amino group |
| 01/16/2002 | EP1171444A1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 01/16/2002 | EP1171443A1 Bicyclic heteroaromatic compounds useful as lh agonists |
| 01/16/2002 | EP1171442A1 Xanthine derivatives and analogs as cell signalling inhibitors |
| 01/16/2002 | EP1171122A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/16/2002 | EP0981529B1 A new process for the preparation of a pharmacologically active substance |
| 01/16/2002 | EP0789700B1 Improved process for making a d-(+)-biotine intermediate product |
| 01/16/2002 | CN1331694A Antihistaminic spiro compounds |
| 01/16/2002 | CN1331692A Benzisozazoles and phenones as alpha antagonist |
| 01/16/2002 | CN1331076A Condensed pyrazole compound, composition containing it and its application |
| 01/15/2002 | US6339089 Antihypoxic agents; chronic obstructive pulmonary disease; vasoconstriction; reduces blood partial pressure of carbon dioxide; respiratory disorders; under oxygen inhalation treatment |
| 01/10/2002 | WO2002002569A1 Substituted thienopyrimidine derivatives and the use thereof for the prophylaxis and therapy of cerebral ischaemia |
| 01/10/2002 | WO2002002568A1 Pyrimidine derivatives and their use for preventing and treating cerebral ischaemia |
| 01/10/2002 | WO2002002567A1 Thienopyrrolidinones |
| 01/10/2002 | WO2002002549A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/10/2002 | WO2002002534A1 Quinazolines with therapeutic use |
| 01/10/2002 | US20020004518 Pyrazolyl compound; anticoagulants, antiproliferative agent |
| 01/10/2002 | US20020004511 Antiproliferative agent |
| 01/10/2002 | US20020004500 Drug mixture for cardiovascular disorders |
| 01/10/2002 | DE10031585A1 2-Aminoalkyl-thieno[2,3-d]pyrimidine 2-aminoalkyl-thieno [2,3-d] pyrimidines |
| 01/10/2002 | CA2414705A1 Thienopyrrolidinones |
| 01/10/2002 | CA2412287A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/09/2002 | EP1169298A2 Pharmaceutical compounds |
| 01/09/2002 | EP1169294A2 Pharmaceutical compounds |
| 01/09/2002 | CN1330640A Cyclic hydrazine derivatives as TNF-alpha inhibitors |
| 01/08/2002 | US6337346 Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents |
| 01/03/2002 | WO2002000664A1 2-aminoalkyl-thieno[2,3-d]pyrimidines |
| 01/03/2002 | WO2002000657A2 Condensed pyrazindione derivatives |
| 01/03/2002 | WO2002000653A2 Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 01/03/2002 | WO2002000626A1 Fused azepine derivatives and their use as antidiuretic agents |
| 01/03/2002 | WO2002000623A2 Aryl fused substituted 4-oxy-pyridines |
| 01/03/2002 | WO2002000617A2 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/03/2002 | WO2001066544A3 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 01/03/2002 | WO2001062233A3 Adenosine receptor modulators |
| 01/03/2002 | WO2000061549A3 Pharmaceutical compounds |
| 01/03/2002 | WO2000055358A9 4-(4-hydroxystyryl)pyridine-containing substrates for an analyte dependent enzyme activation system |
| 01/03/2002 | US20020002287 Cyclization of a dicarboxylated sulfide compound and diester in presence of an alkali metal alkoxide |
| 01/03/2002 | US20020002199 Suitable for treating type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance or obesity |
| 01/03/2002 | US20020002173 E. g., 6-(3-chlorophenyl)-1,4-dihydro-4,4-dimethyl-2H-thieno-(2,3-d)(1,3)oxazine-2 -one; agonists and antagonists of the progesterone receptor; inducing contraception and treating or preventing benign or malignant neoplastic diseases |